Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07465458

Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
226 (estimated)
Sponsor
Humanitas Hospital, Italy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This observational study is designed to expand the current database available in the literature and the existing knowledge on the outcomes and safety of radiofrequency ablation (RFA) for the treatment of primary renal cell carcinomas in stage T1a. All interventions and subsequent follow-ups are clinical decisions are independent of the study, given its observational nature.

Conditions

Interventions

TypeNameDescription
DEVICERadiofrequency Ablation (RFA)Minimally invasive RFA in T1a renal carcinomas

Timeline

Start date
2026-03-01
Primary completion
2028-03-01
Completion
2028-06-01
First posted
2026-03-12
Last updated
2026-03-16

Locations

10 sites across 2 countries: Italy, Spain

Source: ClinicalTrials.gov record NCT07465458. Inclusion in this directory is not an endorsement.

Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients (NCT07465458) · Clinical Trials Directory